TALPHERA, INC. – Trademark Portfolio

Entity Type: 03

TALPHERA, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include NIYAD. The owner is based in SAN MATEO, CA.

1850 GATEWAY DRIVE, SUITE 175

SAN MATEO, CA 94404

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NIYAD
NIYAD
Registered 2022
QUIXFEDA
QUIXFEDA
Abandoned 2022
FEDSYRA
FEDSYRA
Abandoned 2022
EBFEDIS
EBFEDIS
Abandoned 2022

Trademark Classifications

TALPHERA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does TALPHERA, INC. have?

TALPHERA, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 3 abandoned.

What trademark classes does TALPHERA, INC. file in?

TALPHERA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are TALPHERA, INC.'s most well-known trademarks?

TALPHERA, INC.'s registered trademark portfolio includes well-known marks such as NIYAD. These are among 1 currently registered trademark in the portfolio.

What is TALPHERA, INC.'s trademark registration success rate?

TALPHERA, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.